- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Oral Vaccines will have significant change from previous year. By the most conservative estimates of global Oral Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2447.1 million in 2020. Over the next five years the Oral Vaccines market will register a 7.4% CAGR in terms of revenue, the global market size will reach US$ 3251.7 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Public
Private
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Vaccines Consumption 2016-2026
2.1.2 Oral Vaccines Consumption CAGR by Region
2.2 Oral Vaccines Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.2.4 Others
2.3 Oral Vaccines Sales by Type
2.3.1 Global Oral Vaccines Sales Market Share by Type (2016-2021)
2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2016-2021)
2.3.3 Global Oral Vaccines Sale Price by Type (2016-2021)
2.4 Oral Vaccines Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Vaccines Sales by Application
2.5.1 Global Oral Vaccines Sale Market Share by Application (2016-2021)
2.5.2 Global Oral Vaccines Revenue and Market Share by Application (2016-2021)
2.5.3 Global Oral Vaccines Sale Price by Application (2016-2021)
3 Global Oral Vaccines by Company
3.1 Global Oral Vaccines Sales Market Share by Company
3.1.1 Global Oral Vaccines Sales by Company (2019-2021)
3.1.2 Global Oral Vaccines Sales Market Share by Company (2019-2021)
3.2 Global Oral Vaccines Revenue Market Share by Company
3.2.1 Global Oral Vaccines Revenue by Company (2019-2021)
3.2.2 Global Oral Vaccines Revenue Market Share by Company (2019-2021)
3.3 Global Oral Vaccines Sale Price by Company
3.4 Global Manufacturers Oral Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Vaccines Product Location Distribution
3.4.2 Players Oral Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Oral Vaccines by Region
4.1 Global Oral Vaccines by Region
4.1.1 Global Oral Vaccines Sales by Region
4.1.2 Global Oral Vaccines Revenue by Region
4.2 Americas Oral Vaccines Sales Growth
4.3 APAC Oral Vaccines Sales Growth
4.4 Europe Oral Vaccines Sales Growth
4.5 Middle East & Africa Oral Vaccines Sales Growth
5 Americas
5.1 Americas Oral Vaccines Sales by Country
5.1.1 Americas Oral Vaccines Sales by Country (2016-2021)
5.1.2 Americas Oral Vaccines Revenue by Country (2016-2021)
5.2 Americas Oral Vaccines Sales by Type
5.3 Americas Oral Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Vaccines Sales by Region
6.1.1 APAC Oral Vaccines Sales by Region (2016-2021)
6.1.2 APAC Oral Vaccines Revenue by Region (2016-2021)
6.2 APAC Oral Vaccines Sales by Type
6.3 APAC Oral Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oral Vaccines by Country
7.1.1 Europe Oral Vaccines Sales by Country (2016-2021)
7.1.2 Europe Oral Vaccines Revenue by Country (2016-2021)
7.2 Europe Oral Vaccines Sales by Type
7.3 Europe Oral Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Vaccines by Country
8.1.1 Middle East & Africa Oral Vaccines Sales by Country (2016-2021)
8.1.2 Middle East & Africa Oral Vaccines Revenue by Country (2016-2021)
8.2 Middle East & Africa Oral Vaccines Sales by Type
8.3 Middle East & Africa Oral Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Oral Vaccines Distributors
10.3 Oral Vaccines Customer
11 Global Oral Vaccines Market Forecast
11.1 Global Oral Vaccines Forecast by Region
11.1.1 Global Oral Vaccines Forecast by Regions (2021-2026)
11.2.2 Global Oral Vaccines Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Oral Vaccines Forecast by Type
11.7 Global Oral Vaccines Forecast by Application
12 Key Players Analysis
12.1 Merck
12.1.1 Merck Company Information
12.1.2 Merck Oral Vaccines Product Offered
12.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merck Main Business Overview
12.1.5 Merck Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Oral Vaccines Product Offered
12.2.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Sanofi
12.3.1 Sanofi Company Information
12.3.2 Sanofi Oral Vaccines Product Offered
12.3.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sanofi Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 Lanzhou Institute
12.4.1 Lanzhou Institute Company Information
12.4.2 Lanzhou Institute Oral Vaccines Product Offered
12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Lanzhou Institute Main Business Overview
12.4.5 Lanzhou Institute Latest Developments
12.5 Serum Institute
12.5.1 Serum Institute Company Information
12.5.2 Serum Institute Oral Vaccines Product Offered
12.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Serum Institute Main Business Overview
12.5.5 Serum Institute Latest Developments
12.6 Valneva
12.6.1 Valneva Company Information
12.6.2 Valneva Oral Vaccines Product Offered
12.6.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Valneva Main Business Overview
12.6.5 Valneva Latest Developments
12.7 Shanghai United Cell
12.7.1 Shanghai United Cell Company Information
12.7.2 Shanghai United Cell Oral Vaccines Product Offered
12.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Shanghai United Cell Main Business Overview
12.7.5 Shanghai United Cell Latest Developments
12.8 Bibcol
12.8.1 Bibcol Company Information
12.8.2 Bibcol Oral Vaccines Product Offered
12.8.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Bibcol Main Business Overview
12.8.5 Bibcol Latest Developments
12.9 PaxVax
12.9.1 PaxVax Company Information
12.9.2 PaxVax Oral Vaccines Product Offered
12.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 PaxVax Main Business Overview
12.9.5 PaxVax Latest Developments
12.10 Vabiotech
12.10.1 Vabiotech Company Information
12.10.2 Vabiotech Oral Vaccines Product Offered
12.10.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Vabiotech Main Business Overview
12.10.5 Vabiotech Latest Developments
12.11 Tiantan Biological
12.11.1 Tiantan Biological Company Information
12.11.2 Tiantan Biological Oral Vaccines Product Offered
12.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Tiantan Biological Main Business Overview
12.11.5 Tiantan Biological Latest Developments
12.12 EuBiologics
12.12.1 EuBiologics Company Information
12.12.2 EuBiologics Oral Vaccines Product Offered
12.12.3 EuBiologics Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 EuBiologics Main Business Overview
12.12.5 EuBiologics Latest Developments
12.13 Panacea Biotec Ltd
12.13.1 Panacea Biotec Ltd Company Information
12.13.2 Panacea Biotec Ltd Oral Vaccines Product Offered
12.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Panacea Biotec Ltd Main Business Overview
12.13.5 Panacea Biotec Ltd Latest Developments
12.14 Bio-Med
12.14.1 Bio-Med Company Information
12.14.2 Bio-Med Oral Vaccines Product Offered
12.14.3 Bio-Med Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Bio-Med Main Business Overview
12.14.5 Bio-Med Latest Developments
12.15 Halfkin Bio-Pharmaceuticals
12.15.1 Halfkin Bio-Pharmaceuticals Company Information
12.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Offered
12.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
12.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Oral Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Rotavirus Vaccine
Table 3. Major Players of Cholera Vaccine
Table 4. Major Players of Oral Polio Vaccine
Table 5. Major Players of Others
Table 6. Global Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 7. Global Oral Vaccines Sales Market Share by Type (2016-2021)
Table 8. Global Oral Vaccines Revenue by Type (2016-2021) & ($ million)
Table 9. Global Oral Vaccines Revenue Market Share by Type (2016-2021)
Table 10. Global Oral Vaccines Sale Price by Type (2016-2021)
Table 11. Global Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 12. Global Oral Vaccines Sales Market Share by Application (2016-2021)
Table 13. Global Oral Vaccines Value by Application (2016-2021)
Table 14. Global Oral Vaccines Revenue Market Share by Application (2016-2021)
Table 15. Global Oral Vaccines Sale Price by Application (2016-2021)
Table 16. Global Oral Vaccines Sales by Company (2019-2021) & (M Doses)
Table 17. Global Oral Vaccines Sales Market Share by Company (2019-2021)
Table 18. Global Oral Vaccines Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Oral Vaccines Revenue Market Share by Company (2019-2021)
Table 20. Global Oral Vaccines Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Oral Vaccines Producing Area Distribution and Sales Area
Table 22. Players Oral Vaccines Products Offered
Table 23. Oral Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oral Vaccines Sales by Region (2016-2021) (M Doses)
Table 27. Global Oral Vaccines Sales Market Share by Region (2016-2021)
Table 28. Global Oral Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Oral Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Americas Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 31. Americas Oral Vaccines Sales Market Share by Country (2016-2021)
Table 32. Americas Oral Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Americas Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 35. Americas Oral Vaccines Sales Market Share by Type (2016-2021)
Table 36. Americas Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 37. Americas Oral Vaccines Sales Market Share by Application (2016-2021)
Table 38. APAC Oral Vaccines Sales by Region (2016-2021) & (M Doses)
Table 39. APAC Oral Vaccines Sales Market Share by Region (2016-2021)
Table 40. APAC Oral Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Oral Vaccines Revenue Market Share by Region (2016-2021)
Table 42. APAC Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 43. APAC Oral Vaccines Sales Market Share by Type (2016-2021)
Table 44. APAC Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 45. APAC Oral Vaccines Sales Market Share by Application (2016-2021)
Table 46. Europe Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 47. Europe Oral Vaccines Sales Market Share by Country (2016-2021)
Table 48. Europe Oral Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 50. Europe Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 51. Europe Oral Vaccines Sales Market Share by Type (2016-2021)
Table 52. Europe Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 53. Europe Oral Vaccines Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Oral Vaccines Sales by Country (2016-2021) & (M Doses)
Table 55. Middle East & Africa Oral Vaccines Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Oral Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Oral Vaccines Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Oral Vaccines Sales by Type (2016-2021) & (M Doses)
Table 59. Middle East & Africa Oral Vaccines Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Oral Vaccines Sales by Application (2016-2021) & (M Doses)
Table 61. Middle East & Africa Oral Vaccines Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Oral Vaccines
Table 63. Key Application and Potential Industries of Oral Vaccines
Table 64. Key Challenges of Oral Vaccines
Table 65. Key Trends of Oral Vaccines
Table 66. Oral Vaccines Distributors List
Table 67. Oral Vaccines Customer List
Table 68. Global Oral Vaccines Sales Forecast by Region (2021-2026) & (M Doses)
Table 69. Global Oral Vaccines Consumption Market Forecast by Region
Table 70. Global Oral Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Oral Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Oral Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 73. Americas Oral Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Oral Vaccines Sales Forecast by Region (2021-2026) & (M Doses)
Table 75. APAC Oral Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Oral Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 77. Europe Oral Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Oral Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 79. Middle East & Africa Oral Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Oral Vaccines Sales Forecast by Type (2021-2026) & (M Doses)
Table 81. Global Oral Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Oral Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Oral Vaccines Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Oral Vaccines Sales Forecast by Application (2021-2026) & (M Doses)
Table 85. Global Oral Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Oral Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Oral Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 88. Merck Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Oral Vaccines Product Offered
Table 90. Merck Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. GSK Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Oral Vaccines Product Offered
Table 95. GSK Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Sanofi Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Oral Vaccines Product Offered
Table 100. Sanofi Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Lanzhou Institute Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Lanzhou Institute Oral Vaccines Product Offered
Table 105. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 106. Lanzhou Institute Main Business
Table 107. Lanzhou Institute Latest Developments
Table 108. Serum Institute Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Serum Institute Oral Vaccines Product Offered
Table 110. Serum Institute Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 111. Serum Institute Main Business
Table 112. Serum Institute Latest Developments
Table 113. Valneva Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Valneva Oral Vaccines Product Offered
Table 115. Valneva Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 116. Valneva Main Business
Table 117. Valneva Latest Developments
Table 118. Shanghai United Cell Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai United Cell Oral Vaccines Product Offered
Table 120. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 121. Shanghai United Cell Main Business
Table 122. Shanghai United Cell Latest Developments
Table 123. Bibcol Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Bibcol Oral Vaccines Product Offered
Table 125. Bibcol Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 126. Bibcol Main Business
Table 127. Bibcol Latest Developments
Table 128. PaxVax Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. PaxVax Oral Vaccines Product Offered
Table 130. PaxVax Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 131. PaxVax Main Business
Table 132. PaxVax Latest Developments
Table 133. Vabiotech Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Vabiotech Oral Vaccines Product Offered
Table 135. Vabiotech Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 136. Vabiotech Main Business
Table 137. Vabiotech Latest Developments
Table 138. Tiantan Biological Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Tiantan Biological Oral Vaccines Product Offered
Table 140. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 141. Tiantan Biological Main Business
Table 142. Tiantan Biological Latest Developments
Table 143. EuBiologics Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. EuBiologics Oral Vaccines Product Offered
Table 145. EuBiologics Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 146. EuBiologics Main Business
Table 147. EuBiologics Latest Developments
Table 148. Panacea Biotec Ltd Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Panacea Biotec Ltd Oral Vaccines Product Offered
Table 150. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 151. Panacea Biotec Ltd Main Business
Table 152. Panacea Biotec Ltd Latest Developments
Table 153. Bio-Med Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Bio-Med Oral Vaccines Product Offered
Table 155. Bio-Med Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 156. Bio-Med Main Business
Table 157. Bio-Med Latest Developments
Table 158. Halfkin Bio-Pharmaceuticals Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Offered
Table 160. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 161. Halfkin Bio-Pharmaceuticals Main Business
Table 162. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Oral Vaccines
Figure 2. Oral Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Vaccines Sales Growth Rate 2016-2026 (M Doses)
Figure 7. Global Oral Vaccines Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Oral Vaccines Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Rotavirus Vaccine
Figure 10. Product Picture of Cholera Vaccine
Figure 11. Product Picture of Oral Polio Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Oral Vaccines Sales Market Share by Type in 2020
Figure 14. Global Oral Vaccines Revenue Market Share by Type (2016-2021)
Figure 15. Oral Vaccines Consumed in Public
Figure 16. Global Oral Vaccines Market: Public (2016-2021) & (M Doses)
Figure 17. Oral Vaccines Consumed in Private
Figure 18. Global Oral Vaccines Market: Private (2016-2021) & (M Doses)
Figure 19. Global Oral Vaccines Sales Market Share by Application (2016-2021)
Figure 20. Global Oral Vaccines Revenue Market Share by Application in 2020
Figure 21. Oral Vaccines Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Oral Vaccines Revenue Market Share by Company in 2020
Figure 23. Global Oral Vaccines Sales Market Share by Regions (2016-2021)
Figure 24. Global Oral Vaccines Revenue Market Share by Region in 2020
Figure 25. Americas Oral Vaccines Sales 2016-2021 (M Doses)
Figure 26. Americas Oral Vaccines Revenue 2016-2021 ($ Millions)
Figure 27. APAC Oral Vaccines Sales 2016-2021 (M Doses)
Figure 28. APAC Oral Vaccines Revenue 2016-2021 ($ Millions)
Figure 29. Europe Oral Vaccines Sales 2016-2021 (M Doses)
Figure 30. Europe Oral Vaccines Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Oral Vaccines Sales 2016-2021 (M Doses)
Figure 32. Middle East & Africa Oral Vaccines Revenue 2016-2021 ($ Millions)
Figure 33. Americas Oral Vaccines Sales Market Share by Country in 2020
Figure 34. Americas Oral Vaccines Revenue Market Share by Country in 2020
Figure 35. Americas Oral Vaccines Sales Market Share by Type in 2020
Figure 36. Americas Oral Vaccines Sales Market Share by Application in 2020
Figure 37. United States Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Oral Vaccines Sales Market Share by Region in 2020
Figure 42. APAC Oral Vaccines Revenue Market Share by Regions in 2020
Figure 43. APAC Oral Vaccines Sales Market Share by Type in 2020
Figure 44. APAC Oral Vaccines Sales Market Share by Application in 2020
Figure 45. China Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Oral Vaccines Sales Market Share by Country in 2020
Figure 52. Europe Oral Vaccines Revenue Market Share by Country in 2020
Figure 53. Europe Oral Vaccines Sales Market Share by Type in 2020
Figure 54. Europe Oral Vaccines Sales Market Share by Application in 2020
Figure 55. Germany Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Oral Vaccines Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Oral Vaccines Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Oral Vaccines Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Oral Vaccines Sales Market Share by Application in 2020
Figure 64. Egypt Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Oral Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
